DEVELOPMENT AND VALIDATION OF LLE –HPLC METHOD FOR THE DETERMINATION OF RIFAPENTINE IN HUMAN PLASMA

Fuente: Zenodo
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ms. Pranjali Chavan, Ms. Kartiki Kamble, Dr. Paraag Gide
Format: Recurso digital
Veröffentlicht: Zenodo 2025
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866901739828936704
author Ms. Pranjali Chavan
Ms. Kartiki Kamble
Dr. Paraag Gide
author_facet Ms. Pranjali Chavan
Ms. Kartiki Kamble
Dr. Paraag Gide
contents <p>Abstract<br>A simple, accurate, precise and sensitive reverse phase high performance liquid chromatography method was developed for estimation of rifapentine in human plasma by HPLC method using liquid-liquid extraction (LLE) with UV detection. This analytical method was developed by using experimental design and quantification was accomplished with the internal standard method. No interferences were 0bserved from endogenous compounds of plasma. The accuracy of rifapentine from plasma samples, measured at the three levels of the linear concentration range (1-32 μg/ml) were found between 87 and 110.8% . The intraday and interday precision and accuracy. Mobile phase containing methanol: 20mM phosphate buffer pH (6.5) in ration of 80:20 v/v was used. The flow rate was 1 ml/min with the injection volume of 20μL and effluent was monitored at 478nm. Retention time was 8.3 mins. The method was validated for several parameters like accuracy, linearity, [precision etc as per USFDA guidelines. The values of relative standard deviation and % recovery were found to be satisfactory, indicating that the proposed method is precise and accurate and hence can be used for the routine analysis of rifapentine in human plasma.<br>Keywords: Rifapentine, RP-HPLC, Human Plasma, Liquid-Liquid Extraction & Method Validation.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_17621271
institution Zenodo
language
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle DEVELOPMENT AND VALIDATION OF LLE –HPLC METHOD FOR THE DETERMINATION OF RIFAPENTINE IN HUMAN PLASMA
Ms. Pranjali Chavan
Ms. Kartiki Kamble
Dr. Paraag Gide
<p>Abstract<br>A simple, accurate, precise and sensitive reverse phase high performance liquid chromatography method was developed for estimation of rifapentine in human plasma by HPLC method using liquid-liquid extraction (LLE) with UV detection. This analytical method was developed by using experimental design and quantification was accomplished with the internal standard method. No interferences were 0bserved from endogenous compounds of plasma. The accuracy of rifapentine from plasma samples, measured at the three levels of the linear concentration range (1-32 μg/ml) were found between 87 and 110.8% . The intraday and interday precision and accuracy. Mobile phase containing methanol: 20mM phosphate buffer pH (6.5) in ration of 80:20 v/v was used. The flow rate was 1 ml/min with the injection volume of 20μL and effluent was monitored at 478nm. Retention time was 8.3 mins. The method was validated for several parameters like accuracy, linearity, [precision etc as per USFDA guidelines. The values of relative standard deviation and % recovery were found to be satisfactory, indicating that the proposed method is precise and accurate and hence can be used for the routine analysis of rifapentine in human plasma.<br>Keywords: Rifapentine, RP-HPLC, Human Plasma, Liquid-Liquid Extraction & Method Validation.</p>
title DEVELOPMENT AND VALIDATION OF LLE –HPLC METHOD FOR THE DETERMINATION OF RIFAPENTINE IN HUMAN PLASMA
url https://doi.org/10.5281/zenodo.17621271